BVF INC/IL - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, BVF INC/IL held in its portfolio 41 assets valued at $2,970,708,839 (i.e. $2.97B).

The most valuable assets in the portfolio included: KYMERA THERAPEUTICS INC ($428.17M), REVOLUTION MEDICINES INC ($267.37M), and MOONLAKE IMMUNOTHERAPEUTICS ($260.32M).

The chart below shows the top 10 valuable assets, and the table below shows the top 41 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.
Data Source: SEC.
Top Valuable Stocks in BVF INC/IL Portfolio
KYMERA THERAPEUTICS INC
REVOLUTION MEDICINES INC
MOONLAKE IMMUNOTHERAPEUTICS
STRUCTURE THERAPEUTICS INC
OLEMA PHARMACEUTICALS INC
MIRUM PHARMACEUTICALS INC
GH RESEARCH PLC
XENCOR INC
ZYMEWORKS INC
PALVELLA THERAPEUTICS INC NE
BVF INC/IL - Stock Holdings in 13F Filings (SEC)
Items per page:
0 of 0
Name of Issuer No. of Shares Value ($) Class
KYMERA THERAPEUTICS INC 5502710 428165865 COM
REVOLUTION MEDICINES INC 3356782 267367686 COM
MOONLAKE IMMUNOTHERAPEUTICS 19751284 260321923 CLASS A ORD
STRUCTURE THERAPEUTICS INC 3479022 241965980 SPONSORED ADS
OLEMA PHARMACEUTICALS INC 5295893 132397325 COM
MIRUM PHARMACEUTICALS INC 1495290 118112957 COM
GH RESEARCH PLC 8827712 112111942 ORDINARY SHARES
XENCOR INC 7133720 109217253 COM
ZYMEWORKS INC 3938641 103704418 COM
PALVELLA THERAPEUTICS INC NE 879009 92005872 COM
KURA ONCOLOGY INC 8617162 89532313 COM
STOKE THERAPEUTICS INC 2265674 71912493 COM
XOMA ROYALTY CORPORATION 2590303 68876157 COM NEW
ABIVAX SA 508031 68510521 SPONSORED ADS
NEKTAR THERAPEUTICS 1559595 65939677 COM NEW
AC IMMUNE SA 19822436 62242449 SHS
MONTE ROSA THERAPEUTICS INC 3835886 60146692 COM
CULLINAN THERAPEUTICS INC 5750683 59519569 COM
TYRA BIOSCIENCES INC 2127665 55936313 COM
DISC MEDICINE INC 650000 51616500 COM
IMMUNOCORE HLDGS PLC 1488975 50293922 ADS
INVIVYD INC 19525000 48226750 COM
SEPTERNA INC 1720782 47975402 COM
ANNEXON INC 9128080 45822962 COM
COMPASS THERAPEUTICS INC 7764842 41697202 COM
4D MOLECULAR THERAPEUTICS IN 4629289 34719668 COM
CRESCENT BIOPHARMA INC. 2748763 32600329 COM
FOGHORN THERAPEUTICS INC 5302000 28630800 COM
REPARE THERAPEUTICS INC 10333600 26867360 COM
AVALO THERAPEUTICS INC 1355257 24611467 COM NEW
PEPGEN INC 1915000 12466650 COM
ELEDON PHARMACEUTICALS INC 6293282 9502856 COM
X4 PHARMACEUTICALS INC 2233742 8934968 COM NEW
AXSOME THERAPEUTICS INC 45757 8357058 COM
MOLECULAR PARTNERS AG 1353968 5822062 ADS
IMAGENEBIO INC 802102 5534504 COM
TSCAN THERAPEUTICS INC 5226074 5226074 COM
TENAX THERAPEUTICS INC 339549 4139102 COM NEW
IMMUNIC INC 7652972 4084391 COM
INVENTIVA SA 686040 3190086 ADS
ENGENE HOLDINGS INC 945402 2401321 *W EXP 10/31/202